Publication: Membrane transport proteins as therapeutic targets in malaria
Issued Date
2016-08-15
Resource Type
Other identifier(s)
2-s2.0-85024914522
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Recent Advances in Malaria. (2016), 307-324
Suggested Citation
Sanjay A. Desai, Kempaiah Rayavara, Paresh Sharma, Sayeed K. Syed, Wang Nguitragool, Praveen Balabaskaran Nina Membrane transport proteins as therapeutic targets in malaria. Recent Advances in Malaria. (2016), 307-324. doi:10.1002/9781118493816.ch11 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/40773
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Membrane transport proteins as therapeutic targets in malaria
Abstract
© 2017 John Wiley & Sons, Inc. Malaria is leading cause of morbidity and mortality worldwide; estimates of lost productivity in endemic countries are also a call to action. In light of acquired resistance to most antimalarial drugs and a worrying delayed clearance phenotype with artemisinins, the current mainstay of treatment, new drugs with novel mechanisms of action are critically needed. This chapter explores membrane transport proteins of malaria parasites as therapeutic targets. Computational analysis of malaria parasite genomes reveals a paucity of conventional transport proteins with homology to transporters in higher organisms. For each chosen transporter, one have reviewed the evidence for facilitated transmembrane transport, features that distinguish the parasite transporter from similar activities in other systems, reasons that the transporter may be a good drug target, and scientific uncertainties relevant to the drug-development process. Advances in parasite genomic, transfection, and biochemical technologies may be instrumental in translating these basic research findings into future antimalarial drugs.